Interventions in antipsychotics-treated patients with cardiometabolic risk factors or metabolic syndrome

被引：1
|
作者：
Larsen, J. [1 ]
Holdrup, M. [2 ]
Christensen, B. [3 ]
Sigalin, C. [4 ]
Nilsson, P. M. [5 ]
Kolb, S. [6 ]
机构：
[1] Odense Univ Hosp, Dept Psychiat, Odense C, Denmark
[2] 3MDS Pharma Serv, Copenhagen, Denmark
[3] Aalborg Psychiat Hosp, Dept Psychiat, Aalborg, Denmark
[4] Ryhov Cty Hosp, Dept Psychiat, Jonkoping, Sweden
[5] Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden
[6] Pfizer, Med Affairs, Walton Oaks, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70648-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S440 / S441
页数：2
相关论文
共 50 条
  • [21] Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients
    Guo, Yi
    Luo, Shiyun
    Ye, Yongxin
    Yin, Songping
    Fan, Jiahua
    Xia, Min
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01): : 64 - 79
  • [22] Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors
    Y C Chang
    J-W Lin
    L C Wang
    H M Chen
    J J Hwang
    L M Chuang
    Eye, 2010, 24 : 1037 - 1043
  • [23] Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors
    Chang, Y. C.
    Lin, J-W
    Wang, L. C.
    Chen, H. M.
    Hwang, J. J.
    Chuang, L. M.
    EYE, 2010, 24 (06) : 1037 - 1043
  • [24] Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
    Boodai, Shurooq A.
    Cherry, Lynne M.
    Sattar, Naveed A.
    Reilly, John J.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 505 - 511
  • [25] Metabolic syndrome and cardiometabolic risk: An update
    Grassi, Guido
    Seravalle, Gino
    Quarti-Trevano, Fosca
    Dell'ro, Raffaella
    Bombelli, Michele
    Mancia, Giuseppe
    BLOOD PRESSURE, 2009, 18 (1-2) : 7 - 16
  • [26] Metabolic syndrome and cardiometabolic risk in PCOS
    Cussons A.J.
    Stuckey B.G.A.
    Watts G.F.
    Current Diabetes Reports, 2007, 7 (1) : 66 - 73
  • [27] Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics
    Correll, Christoph U.
    Frederickson, Anne M.
    Kane, John M.
    Manu, Peter
    BIPOLAR DISORDERS, 2008, 10 (07) : 788 - 797
  • [28] Metabolic Syndrome in people treated with Antipsychotics (RISKMet): A multimethod study protocol investigating genetic, behavioural, and environmental risk factors
    de Girolamo, Giovanni
    La Cascia, Caterina
    Macchia, Paolo Emidio
    Nobile, Maria
    Calza, Stefano
    Camillo, Laura
    Mauri, Maddalena
    Pozzi, Marco
    Tripoli, Giada
    Vetrani, Claudia
    Caselani, Elisa
    Magno, Marta
    PLOS ONE, 2024, 19 (05):
  • [29] Impact of Hypoxia-Hyperoxia Exposures on Cardiometabolic Risk Factors and TMAO Levels in Patients with Metabolic Syndrome
    Bestavashvili, Afina
    Glazachev, Oleg
    Ibragimova, Shabnam
    Suvorov, Alexander
    Bestavasvili, Alexandros
    Ibraimov, Shevket
    Zhang, Xinliang
    Zhang, Yong
    Pavlov, Chavdar
    Syrkina, Elena
    Syrkin, Abram
    Kopylov, Philipp
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [30] Ziprasidone switching effects on metabolic syndrome in patients treated with others atypical antipsychotics
    Grigorescu, R.
    Voicu, V.
    Vasile, D.
    Grigorescu, G.
    Staicu, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S495 - S495
12345